Cite
HARVARD Citation
Owari, T. et al. (2019). Clinical benefit of early treatment with bone‐modifying agents for preventing skeletal‐related events in patients with genitourinary cancer with bone metastasis: A multi‐institutional retrospective study. International journal of urology. pp. 630-637. [Online].